-
Mashup Score: 0Abbott Receives FDA Approval for Epic Max Tissue Valve to Treat Aortic Valve Disease - 1 year(s) ago
March 31, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Epic Max stented tissue valve to treat people with aortic regurgitation or stenosis. This device is the latest addition to Abbott’s Epic surgical valve platform which has a decades-long history of safety and strong clinical outcomes, with an optimized design to further improve valve blood…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Interventional Echocardiographer Lucy Safi, MD, FACC, will review the essential clinical and imaging aspects of patient selection, imaging evaluation, and intraprocedural guidance for optimal results using this transcatheter device therapy. Register today to secure your FREE CME!
Source: ZoomCategories: Cardiologists, Latest HeadlinesTweet-
Register and join us tonight at 7 PM EST for (1 hour CME) on the role of #Echo for #Mitral #Valve #Regurgitation & #MitraClip Procedure with Dr @LucySafi Registration: https://t.co/DRDSTYHlCI https://t.co/RDQvXRuGL5
-
Register and join us tonight at 7 PM EST for (1 hour CME) on the role of #Echo for #Mitral #Valve #Regurgitation & #MitraClip Procedure with Dr @LucySafi. Registration: https://t.co/DRDSTYHlCI #ACC23 #SCAI2023 #Echo #PCI #SSHD #healtheducation #healthcare https://t.co/bbhddRSLss
-
-
Mashup Score: 63Acute mitral regurgitation - 1 year(s) ago
The diagnosis of acute mitral regurgitation (MR) is often missed or delayed because the clinical presentation is substantially different from that in patients with chronic MR. Management of acute MR depends on the specific aetiology of valve dysfunction and there is a lack of consensus on the optimal therapeutic approach in many patients. In particular, management of secondary MR due to acute…
Source: HeartCategories: Cardiologists, Latest HeadlinesTweet-
RT @iamritu: #visualgraphic #acute #mitral #regurgitation https://t.co/cPBLQeYMbF 1 endocarditis 2 PM rupture 3 ischemia 4 iatrogenic dev…
-
-
Mashup Score: 0Post | LinkedIn - 1 year(s) ago
Univ.-Prof.Dr. Ralph Stephan von Bardeleben Univ.-Professor, Head Heart Valve Center, Herz.Klappen.Bewegen.Leben. Editor in Chief Echocardiography, Full Professor Interventional Heart Valve Tx Cardiology JGU University of Mainz, ACHD EMAH View full profile
Source: www.linkedin.comCategories: Cardiologists, Latest HeadlinesTweet-
@vonBardelebenRS at #cardiovascularnews on new options in #Aorticvalve #regurgitation #interview @PCRonline #pcrlv https://t.co/PfRqNWdYmZ
-
-
Mashup Score: 0
January 31, 2023 — Serotonin can impact the mitral valve of the heart and potentially accelerate a cardiac condition known as degenerative mitral regurgitation, according to a new study led by researchers at Columbia University’s Department of Surgery in collaboration with the Pediatric Heart Valve Center at Children’s Hospital of Philadelphia (CHOP), the University of Pennsylvania, and the…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @ColumbiaSurgery @ChildrensPhila #Serotonin can impact the #mitralvalve of the #heart and potentially accelerate a #cardiac condition known as #degenerative #mitral #regurgitation, according to a new #study: https://t.co/tUK8QG831d
-
-
Mashup Score: 0(1) Post | LinkedIn - 1 year(s) ago
Univ.-Prof.Dr. Ralph Stephan von Bardeleben Univ.-Professor, Head Heart Valve Center, Herz.Klappen.Bewegen.Leben. Editor in Chief Echocardiography, Full Professor Interventional Heart Valve Tx Cardiology JGU University of Mainz, ACHD EMAH View full profile
Source: www.linkedin.comCategories: Cardiologists, Latest HeadlinesTweet-
#Aorticvalve #regurgitation #JenaValve #TAVR #TAVI interview https://t.co/PfRqNWdYmZ
-
-
Mashup Score: 3Valvular heart diseases in women: facts vs. incantations - 1 year(s) ago
This editorial refers to ‘Sex-related characteristics and short-term outcomes of patients undergoing transcatheter tricuspid valve intervention for tricuspid re
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Dive into the many differences between valvular heart disease and tricuspid regurgitation in men and women! https://t.co/E4wavip3u4 #tricuspid #regurgitation #valve #heart #disease #cardiotwitter #EHJ @ESC_Journals @escardio @sarano_maurice https://t.co/FUgQnhtpGd
-
-
Mashup Score: 6How and When to Intervene for Secondary Mitral Regurgitation - 1 year(s) ago
Focus on the latest guideline recommendations, controversies, and innovative treatment strategies for the management of chronic secondary mitral valve regurgitation.
Source: MedscapeCategories: Latest Headlines, SurgeryTweet-
➡️ Focus on the latest guideline recommendations, controversies, & innovative treatment strategies for the management of chronic secondary mitral valve #regurgitation. #MedEd #CME #MedTwitter #Surgery 📍 https://t.co/jPG7m0uEiH https://t.co/zsk6ENv3Hy
-
-
Mashup Score: 2How and When to Intervene for Secondary Mitral Regurgitation - 1 year(s) ago
Focus on the latest guideline recommendations, controversies, and innovative treatment strategies for the management of chronic secondary mitral valve regurgitation.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
➡️ Focus on the latest guideline recommendations, controversies, and innovative treatment strategies for the management of chronic secondary mitral valve #regurgitation. #MedEd #CME 📍 https://t.co/NpVZto0dvm https://t.co/a9MmWbfSjb
-
-
Mashup Score: 1How and When to Intervene for Secondary Mitral Regurgitation - 1 year(s) ago
Focus on the latest guideline recommendations, controversies, and innovative treatment strategies for the management of chronic secondary mitral valve regurgitation.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
➡️ Focus on the latest guideline recommendations, controversies, and innovative treatment strategies for the management of chronic secondary mitral valve #regurgitation. #MedEd #CME #MedTwitter #CardioTwitter 📍 https://t.co/YpcfNLRM30 https://t.co/3H6qE1NtqV
-
@DAICeditor @AbbottNews Abbott announced that the U.S. Food and Drug Administration (#FDA) has approved the company's #EpicMax stented tissue valve to treat people with #aortic #regurgitation or #stenosis: https://t.co/dEBy07lL9K